QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
NASDAQ:LITE

Lumentum - LITE Price Target & Analyst Ratings

$89.60
-6.59 (-6.85%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$88.75
$93.00
50-Day Range
$75.21
$96.19
52-Week Range
$73.97
$108.90
Volume
2.83 million shs
Average Volume
930,673 shs
Market Capitalization
$6.18 billion
P/E Ratio
36.42
Dividend Yield
N/A
Price Target
$108.92

Lumentum Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 13 Analyst Ratings

Consensus Analyst Price Target

$108.92
21.57% Upside
High Prediction$125.00
Average Prediction$108.92
Low Prediction$93.00
TypeCurrent
8/16/21 to 8/16/22
1 Month Ago
7/17/21 to 7/17/22
3 Months Ago
5/18/21 to 5/18/22
1 Year Ago
8/16/20 to 8/16/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
9 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$108.92$110.15$107.36$94.50
Predicted Upside21.57% Upside25.08% Upside21.25% Upside25.75% Upside
Get Lumentum Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for LITE and its competitors with MarketBeat's FREE daily newsletter.


LITE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LITE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lumentum Stock vs. The Competition

TypeLumentumComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.92
2.59
2.50
Consensus RatingModerate BuyBuyHold
Predicted Upside21.57% Upside202.78% Upside13.26% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
854
74.98%
Underperform Votes
285
25.02%
Avg. Outperform Votes
221
66.97%
Avg. Underperform Votes
109
33.03%
Avg. Outperform Votes
854
68.59%
Avg. Underperform Votes
391
31.41%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/15/2022Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$125.00+29.95%
8/4/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$118.00 ➝ $102.00+11.71%
7/25/2022Susquehanna Bancshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$105.00+24.35%
7/25/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$100.00 ➝ $95.00+11.74%
7/14/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Samik Chatterjee
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight$115.00 ➝ $100.00+29.87%
6/6/2022Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Alex Henderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$125.00+45.94%
5/5/2022B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Kang
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$120.00 ➝ $119.00+32.96%
3/23/2022Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Hans Mosesmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$115.00 ➝ $125.00+34.25%
3/9/2022Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$110.00 ➝ $120.00+32.46%
2/4/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight$91.00 ➝ $97.00+10.50%
8/19/2021Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$90.00 ➝ $100.00+18.32%
8/19/2021MKM Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Fahad Najam
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$86.00 ➝ $93.00+12.85%
6/1/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$104.00 ➝ $86.00+5.69%
5/13/2021DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetIn-Line ➝ Buy$110.00 ➝ $95.00+42.92%
1/20/2021Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$98.00+3.59%
10/8/2020Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$105.00 ➝ $115.00+39.82%
5/6/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$95.00 ➝ $100.00+21.89%
1/9/2020UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Tejas Venkatesh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$71.00 ➝ $85.00+2.46%
(Data available from 8/16/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












LITE Price Target - Frequently Asked Questions

What is Lumentum's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Lumentum stock is Moderate Buy based on the current 1 hold rating and 12 buy ratings for LITE. The average twelve-month price prediction for Lumentum is $108.92 with a high price target of $125.00 and a low price target of $93.00. Learn more on LITE's analyst rating history.

Do Wall Street analysts like Lumentum more than its competitors?

Analysts like Lumentum more than other Computer and Technology companies. The consensus rating for Lumentum is Moderate Buy while the average consensus rating for computer and technology companies is Buy. Learn more on how LITE compares to other companies.

Do MarketBeat users like Lumentum more than its competitors?

MarketBeat users like Lumentum more than other Computer and Technology companies. 74.98% of MarketBeat users gave Lumentum an outperform vote while computer and technology companies recieve an average of 67.07% outperform votes by MarketBeat users.

Does Lumentum's stock price have much upside?

According to analysts, Lumentum's stock has a predicted upside of 23.10% based on their 12-month price targets.

What analysts cover Lumentum?

Lumentum has been rated by Barclays, Craig Hallum, JPMorgan Chase & Co., Needham & Company LLC, Raymond James, and Susquehanna Bancshares in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:LITE) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.